Anton Wellstein Selected Research

Messenger RNA (mRNA)

7/2023	Loss of ANCO1 Expression Regulates Chromatin Accessibility and Drives Progression of Early-Stage Triple-Negative Breast Cancer.
1/2021	Cadherin 11 Promotes Immunosuppression and Extracellular Matrix Deposition to Support Growth of Pancreatic Tumors and Resistance to Gemcitabine in Mice.
1/2016	Circulating biomarkers to monitor cancer progression and treatment.
7/2013	Transcriptional repression of AIB1 by FoxG1 leads to apoptosis in breast cancer cells.
8/2007	Effects on neurite outgrowth and cell survival of a secreted fibroblast growth factor binding protein upregulated during spinal cord injury.
1/2006	Expression of a fibroblast growth factor-binding protein during the development of adenocarcinoma of the pancreas and colon.
9/2004	Overexpression of the nuclear receptor coactivator AIB1 (SRC-3) during progression of pancreatic adenocarcinoma.
10/2002	A role for TGF-beta in estrogen and retinoid mediated regulation of the nuclear receptor coactivator AIB1 in MCF-7 breast cancer cells.
4/2002	Pleiotrophin signaling through anaplastic lymphoma kinase is rate-limiting for glioblastoma growth.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anton Wellstein Research Topics

Disease

54	Neoplasms (Cancer) 01/2024 - 03/2002
28	Breast Neoplasms (Breast Cancer) 07/2023 - 10/2002
10	Pancreatic Neoplasms (Pancreatic Cancer) 03/2022 - 03/2002
6	Disease Progression 12/2018 - 12/2012
6	Wounds and Injuries (Trauma) 01/2018 - 11/2011
6	Carcinogenesis 01/2018 - 09/2002
5	Neoplasm Metastasis (Metastasis) 03/2023 - 03/2004
5	Adenocarcinoma 11/2019 - 09/2004
4	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2021 - 05/2018
3	Inflammation (Inflammations) 01/2021 - 01/2018
3	Chronic Renal Insufficiency 11/2018 - 05/2015
3	Hypertension (High Blood Pressure) 01/2018 - 02/2006
3	Colorectal Neoplasms (Colorectal Cancer) 01/2014 - 01/2006
3	Glioblastoma (Glioblastoma Multiforme) 01/2012 - 04/2002
2	Triple Negative Breast Neoplasms 07/2023 - 01/2021
2	Cardiotoxicity 09/2021 - 01/2018
2	Pancreatitis 01/2021 - 09/2004
2	Papilloma (Papillomatosis) 01/2018 - 09/2004
2	Colonic Neoplasms (Colon Cancer) 01/2014 - 12/2006
1	Unilateral Breast Neoplasms 01/2023
1	Esophageal Neoplasms (Esophageal Cancer) 09/2021
1	Acute Kidney Injury (Acute Renal Failure) 12/2020
1	Reperfusion Injury 12/2020
1	Ductal Carcinoma 01/2020
1	Ovarian Neoplasms (Ovarian Cancer) 12/2019
1	Diabetes Mellitus 01/2019
1	Diabetic Angiopathies (Diabetic Angiopathy) 01/2019
1	Hyperglycemia 10/2018
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2018
1	Weight Gain 10/2018
1	Second Primary Neoplasms (Neoplasms, Second) 01/2018

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 07/2023 - 09/2002
14	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 06/2014 - 10/2002
13	Carrier Proteins (Binding Protein)IBA 12/2020 - 04/2003
13	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 12/2020 - 04/2003
11	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2017 - 03/2002
9	Messenger RNA (mRNA)IBA 07/2023 - 04/2002
8	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 06/2015
7	Hormones (Hormone)IBA 03/2023 - 05/2003
7	MicroRNAs (MicroRNA)IBA 03/2022 - 01/2011
6	Cell-Free Nucleic AcidsIBA 01/2021 - 06/2015
5	Steroid Receptors (Steroid Receptor)IBA 01/2023 - 09/2006
5	Estrogen Receptor alphaIBA 01/2023 - 05/2003
5	pleiotrophin (HARP)IBA 01/2023 - 03/2002
5	Phosphotransferases (Kinase)IBA 03/2022 - 04/2002
5	Angiotensin IIIBA 01/2021 - 02/2012
5	Biomarkers (Surrogate Marker)IBA 12/2019 - 01/2006
4	Protein Isoforms (Isoforms)IBA 01/2023 - 01/2004
4	CytokinesIBA 01/2023 - 02/2004
4	Estrogens (Estrogen)FDA Link 01/2011 - 10/2002
4	Epidermal Growth Factor (EGF)IBA 07/2009 - 05/2003
3	RNA (Ribonucleic Acid)IBA 03/2023 - 01/2016
3	Anaplastic Lymphoma KinaseIBA 03/2022 - 04/2002
3	Estrogen ReceptorsIBA 12/2019 - 11/2004
3	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2018 - 07/2012
3	SteroidsIBA 04/2012 - 09/2006
3	Insulin-Like Growth Factor I (IGF-1)IBA 11/2004 - 05/2003
2	Sepharose (Agarose)IBA 01/2024 - 01/2020
2	palbociclibIBA 03/2023 - 12/2019
2	Gemcitabine FDA Link 01/2021 - 01/2011
2	Vasoconstrictor AgentsIBA 12/2020 - 01/2019
2	ProstaglandinsIBA 01/2019 - 05/2015
2	Glucose (Dextrose)FDA LinkGeneric 10/2018 - 12/2012
2	Tyrosine Kinase InhibitorsIBA 01/2018 - 10/2017
2	CarcinogensIBA 01/2018 - 09/2004
2	matrigelIBA 01/2018 - 11/2011
2	Heparin (Liquaemin)FDA LinkGeneric 09/2017 - 01/2016
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2015 - 05/2015
2	NADPH Oxidases (NAD(P)H oxidase)IBA 07/2012 - 02/2006
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2012 - 11/2008
2	tyrosine receptor (receptor, tyrosine)IBA 01/2012 - 04/2002
2	Tyrosine (L-Tyrosine)FDA Link 11/2008 - 08/2007
2	Cyclin D1IBA 05/2008 - 03/2004
2	Staphylococcal Protein A (Protein A)IBA 12/2006 - 01/2006
2	Indicators and Reagents (Reagents)IBA 12/2006 - 12/2006
1	ChromatinIBA 07/2023
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 03/2022
1	NVP-TAE684IBA 03/2022
1	PD 173074IBA 03/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2021
1	Carboplatin (JM8)FDA LinkGeneric 09/2021
1	Glycoproteins (Glycoprotein)IBA 01/2021
1	osteoblast cadherinIBA 01/2021
1	Versicans (Versican)IBA 01/2021
1	Circulating Tumor DNAIBA 01/2021
1	Collagen Type I (Type I Collagen)IBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	Phenobarbital (Luminal)FDA Link 12/2019
1	Fenofibrate (CiL)FDA LinkGeneric 01/2019
1	SaltsIBA 11/2018
1	Nonesterified Fatty Acids (NEFA)IBA 10/2018
1	AdiponectinIBA 10/2018
1	efatutazoneIBA 05/2018
1	2-tert-butylhydroquinone (tert-butylhydroquinone)IBA 01/2018

Therapy/Procedure

11	Therapeutics 01/2023 - 03/2004
3	Radiotherapy 01/2023 - 01/2018
1	Neoadjuvant Therapy 09/2021
1	Injections 01/2021
1	Immunotherapy 01/2020
1	Drug Therapy (Chemotherapy) 01/2018